首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Oncoimmunology

缩写:ONCOIMMUNOLOGY

ISSN:2162-402X

e-ISSN:2162-402X

IF/分区:6.3/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引892
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Pablo Morgado-Cáceres,Francisca Hofmann-Vega,Diego Figueroa et al. Pablo Morgado-Cáceres et al.
Therapeutic immunization against tumor neoantigens has the potential to induce potent and highly selective CD8+ T-cell-mediated antitumor immunity. Consequently, immunization strategies that generate robust neoantigen-specific T-cell respon...
Yi Tang,Qinzhi E,Liang Ma et al. Yi Tang et al.
Glioblastoma (GBM) remains therapeutically challenging due to treatment resistance and immunosuppression. Oncolytic virotherapy offers a promising strategy. This study engineered OVV-03, a novel HER2-armed oncolytic vesicular stomatitis vir...
Minji Lim,Sang-Eun Jung,Choong-Hyun Koh et al. Minji Lim et al.
Liver X receptor β (LXRβ) is a key transcription factor involved in lipid metabolism and immune regulation, yet its functional role in tumor-infiltrating T cells remains largely unresolved. While LXRβ has been shown to suppress NF-κB ta...
M M Cogels,A de Caluwé,L Buisseret et al. M M Cogels et al.
The immunomodulatory potential of radiotherapy provides a strong rationale for its combination with immunotherapies and other immunostimulatory agents. However, current combinations yield suboptimal clinical benefits. As the mechanisms behi...
Rômulo Gonçalves Agostinho Galvani,Adolfo Alexis Rojas Hidalgo,Carlos Alberto Biagi-Junior et al. Rômulo Gonçalves Agostinho Galvani et al.
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. HPV-negative HNSCC, arising in diverse upper airway mucosal niches, is particularly aggressive, with poor 5-y survival and a limited response to immune...
Phurin Areesawangkit,Karen Pei-Yi Fong,Emma Niemeyer et al. Phurin Areesawangkit et al.
Endogenous or adoptively transferred tumor-infiltrating lymphocytes (TILs) often lose their functional capacity due to the activation of intrinsic inhibitory pathways, which then limits their ability to control tumor growth. In this study, ...
Nadine Landolina,Francesca Romana Mariotti,Enrico Munari et al. Nadine Landolina et al.
Interleukin (IL)-37 is one of the "youngest" IL-1 family members and one of the few molecules exerting anti-inflammatory activity. Upon inflammasome activation, the cytokine precursor is converted into its mature form, which acts intracellu...
Britney Niemann,Abby Ivey,Quinn Hopen et al. Britney Niemann et al.
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with poor survival. The immunosuppressive tumor microenvironment (TME) drives resistance to therapy, including immunotherapy. This may be, in part, mediated by the formation o...
Na Li,Jiamin He,Mengjiao Chen et al. Na Li et al.
Pancreatic ductal adenocarcinoma (PDAC) responds poorly to immune checkpoint inhibitors (ICIs), representingindicating an unmet clinical need. Hyperthermia therapy, an approved anti-cancer approach with limited adverse effects, has been sug...
Hugo Boutier,Jürgen Kogler,Liliana R Loureiro et al. Hugo Boutier et al.
The fibroblast activation protein alpha (FAPα) is overexpressed in the tumor microenvironment of most solid cancers and, in some cases, in cancer cells, making it an interesting target for theranostic applications. T-cells modified to expr...